# ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices

> **NCT03774615** · PHASE4 · TERMINATED · sponsor: **Hannover Medical School** · enrollment: 11 (actual)

## Conditions studied

- Heart Failure, Left Sided
- Anemia, Iron Deficiency

## Interventions

- **DRUG:** Ferric maltol 30 mg (Feraccru®)

## Key facts

- **NCT ID:** NCT03774615
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-11-29
- **Final completion:** 2019-11-29
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** low recruitment rate; difficulties to achieve planned number of participants within reasonable time frame
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774615, "ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03774615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*